Nevro (NYSE:NVRO) announced today that it priced concurrent underwritten public offerings of more than 1.6 million common stock shares, as well as convertible senior notes, to raise more than $300 million. The offering of 1,625,000 total shares of common stock at a price of $84.00 per share is slated to bring gross proceeds of approximately $136.5 […]
CHF Solutions prices $2.2m offering
CHF Solutions (NSDQ:CHFS) announced today that it priced a registered direct offering of common stock worth approximately $2.2 million. The Eden Prairie, Minn.-based ultrafiltration therapy developer is offering more than 5.1 million shares of its common stock at a public price of approximately 43¢ per share. CHF Solutions expects gross proceeds of $2,226,000 prior to the […]
ElectroCore selling up to $25m in stock to Lincoln Park
ElectroCore (NSDQ:ECOR) announced today that it entered into a purchase agreement in which the neuroscience company has the right to sell shares of its common stock worth up to $25 million to Lincoln Park Capital Fund. Basking Ridge, N.J.-based ElectroCore would control the timing and amount of any sales of its common stock, valued at $0.001 […]
Royal Philips prices €1b offering
Royal Philips (NYSE:PHG) announced that it completed the pricing of a €1 billion ($1.1 billion) offering worth two sets of €500 million in fixed-rate notes due five years apart. The offering includes €500 million in fixed-rate notes due in 2025 and another set of €500 million fixed-rate notes due in 2030. The issue price for the […]
Thermo Fisher lines up financing for Qiagen buy
Thermo Fisher Scientific (NYSE:TMO) confirmed in a prospectus supplement that it is in part financing its $11.5 billion purchase of Qiagen (NYSE:QGEN) with an offering worth $2.2 billion. The offering includes $1.1 billion in 4.133% senior notes due in 2025 and another $1.1 billion in 4.497% senior notes due in 2030. Thermo Fisher said in its prospectus […]
Sight Sciences raises $30m in Series E round
Growth-stage ophthalmology and optometry device developer Sight Sciences announced today that it closed a Series E preferred stock financing round totaling over $30 million. The Menlo Park, Calif.–based company — which develops treatments for glaucoma and dry eye disease — said in a news release that the proceeds from the funding are earmarked for clinical […]
OtoNexus raises $9.8m
OtoNexus Medical Technologies filed an amendment to its SEC Form D last week to confirm the sale of nearly $10 million in an equity offering. The Seattle-based ultrasound technology maker sold approximately $9.77 million of an $18.2 million offering, leaving just over $8.4 million remaining to be sold, according to the filing. OtoNexus made the […]
Eyebrain Medical raises $23.8m
Eyebrain Medical yesterday filed an amendment to its SEC Form D to confirm the sale of more than $23.8 million in an equity offering. The offering is slated to collect just shy of $24 million, leaving the Costa Mesa, Calif.-based company with $180,026 remaining to be sold. Eyebrain Medical made the first sale on July […]
Insightec raises another $150m for incisionless neurosurgery platform
Insightec announced that it signed definitive agreements for a $150 million Series F financing round with a post-money valuation of $1.3 billion. The Haifa, Israel–based company is the developer of the Exablate Neuro incisionless neurosurgery platform. Insightec touts the Exablate Neuro as the first MR-guided focused ultrasound device to win FDA approval for treating certain […]
JLL Ventures joins biomed veteran in $100m launch of Renovo Health
JLL Partners announced that it entered into a partnership with Bart Doedens to form Renovo Health, committing $100 million to build the materials technology company. Renovo Health is set up to buy, build and develop materials technologies to improve efficacy across medical and dental procedures with an opportunity for near-term expansion, according to a news […]
Hologic gets U.S. funding for coronavirus test kit
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is offering advanced development support to Hologic (NSDQ:HOLX) for a molecular diagnostic test for coronavirus (COVID-19). Marlborough, Mass.-based Hologic’s test is the first coronavirus product selected for development through ASPR’s biomedical advanced R&D authority streamlined selection process (BARDA), […]
- 1
- 2
- 3
- …
- 204
- Next Page »
